SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-048114
Filing Date
2024-12-02
Accepted
2024-12-02 08:26:07
Documents
15
Period of Report
2024-12-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20039399_8k.htm   iXBRL 8-K 31971
2 EXHIBIT 99.1 ef20039399_ex99-1.htm EX-99.1 41179
6 image00001.jpg GRAPHIC 2387
  Complete submission text file 0001140361-24-048114.txt   229975

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA snti-20241202.xsd EX-101.SCH 3983
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE snti-20241202_lab.xml EX-101.LAB 22691
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snti-20241202_pre.xml EX-101.PRE 16553
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20039399_8k_htm.xml XML 4398
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

IRS No.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40440 | Film No.: 241517474
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)